
For Successor Physicians
$464K: The Ophthalmology Average That Ownership Decides
Ophthalmology posted one of the strongest years in medicine for 2025. Average total compensation landed at roughly $464,000, up about 9% year over year, according to Medscape's 2026 Ophthalmologist Compensation Report. That growth outpaced the 3% average increase physicians saw generally, and it outpaced the 2.7% inflation figure Medscape used as its benchmark. On paper, that's a specialty having a very good year.
Why the Number Moved
Matthew Wells, PhD, a senior director at AMGA Consulting, calls 2025 a return to normalization for physician compensation broadly, and points to two forces behind gains this strong. Physicians are seeing more patients and generating more work RVUs, and better back office technology has made practices more efficient at capturing and billing for the work they're already doing. Growth reflects real productivity gains and administrative efficiency rather than a simple market correction, which matters because it means the underlying driver isn't a one year fluke.
But an average is a single point sitting inside a much wider spread, and where any individual ophthalmologist actually lands inside that spread depends far less on how many years they've practiced than most people assume.
Where Ophthalmology Sits Among Its Peers
Eight physician specialties cleared $500,000 in average total compensation in the 2026 report: orthopedics, cardiology, radiology, plastic surgery, anesthesiology, urology, gastroenterology, and otolaryngology. Ophthalmology's $464,000 average sits just under that tier, close enough that the real gap has less to do with the specialty's earning ceiling and everything to do with how many ophthalmologists are actually operating at the top of their own distribution versus sitting well below it.
That's the more useful way to read the number: a midpoint blending physicians who clear $600,000 together with physicians earning far less, rather than a ceiling any individual is bumping against. The report is fairly specific about what separates the two groups.
What Actually Separates the Top of the Range
Angie Caldwell, a principal with PYA Accountants & Advisors, points directly at the mechanism in Medscape's report. She ties the specialty's stronger earners to physicians who hold ownership in their own ambulatory surgery center, alongside higher procedure volume and more time spent in private practice rather than an employed hospital setting. Her read is straightforward: ownership interest in the facility where the work happens is doing real work on the compensation number, well beyond years in practice.
That distinction reframes what's actually driving the spread. Seniority still matters at the margins, but structure does the heavy lifting once a physician clears the specialty average. A physician ten years into practice as a hospital employee and a physician five years in who owns a piece of their surgery center aren't competing on the same axis at all. One collects a salary set by someone else's compensation philosophy. The other captures a share of the facility economics generated by their own clinical work.
An older Medscape report put an actual number on that gap. Self-employed ophthalmologists averaged $395,000 against $361,000 for employed ophthalmologists in the same specialty, with physician partners out-earning both groups. Those figures have moved since, but the direction hasn't changed in any report Medscape has published since it started asking the question. Ownership has outpaced employment in this specialty consistently, not occasionally.
Why the Ownership Premium Keeps Growing
This isn't unique to ophthalmology, but ophthalmology is unusually well positioned to benefit from it. Ambulatory surgery center ownership has become one of the single most consequential value drivers in ophthalmology transactions, and in an acquisition context, a practice with an owned ASC can command a meaningfully higher valuation multiple than an otherwise identical practice without one. That's the buy-side proof of the same story Caldwell is describing on the compensation side. The market prices ownership at a premium because ownership is where the actual economics of the visit get captured, not just the professional fee for performing it.
Ophthalmology also remains one of the more independent specialties left in American medicine, with roughly 70% of ophthalmologists still practicing independently compared to about 42% of physicians overall. That's a meaningfully different starting position than most specialties face today, and it's part of why the ownership premium in this field is so pronounced. A large, genuinely independent base of practices still exists where this decision hasn't already been made for the physician by an employer.
The trend also isn't flattening. Ophthalmologists expecting a pay increase this year jumped to 45%, up sharply from 27% in the prior report, while only 17% expect their pay to fall. Whatever's driving the specialty's growth, more ophthalmologists expect it to keep going than not, which raises the stakes on which side of the ownership line a physician sits on while it does.
Why Higher Pay Doesn't Always Feel Fair
Despite the specialty's strong growth, only 49% of ophthalmologists in the 2026 report said they feel fairly compensated. Danielle DuBord, a senior consultant at AMGA, points out that perceived fairness gets shaped by far more than the number on the paycheck. Staffing shortages, scheduling pressure, and administrative load can all leave a physician feeling undercompensated even when the underlying comp structure is objectively strong.
Some of that pressure has nothing to do with any individual physician's productivity at all. Caldwell also points to the declining Medicare conversion factor as a headwind squeezing reimbursement even as demand for care keeps climbing, a pressure that lands on every ophthalmologist regardless of how many patients they see or how well they perform. An employed physician absorbs that pressure as a flat number set from above. An owner absorbs it too, but as one input into a business they control, with other levers, like ASC ownership and premium services, available to offset it.
That gap between rising averages and flat satisfaction is worth sitting with. A bigger number alone doesn't fix how compensation actually feels day to day, especially for a physician whose pay is set entirely by someone else's formula and whose say in their own working conditions is limited by that same structure. Ownership changes both halves of that equation at once. It changes the number, and it changes who has a say in the conditions the number gets earned under.
The Average Is One Number. Ownership Decides Which Side of It You're On
$464,000 tells you where the specialty sits today. It doesn't tell you who's above that line and who's below it, or why. The report is fairly direct about the answer: procedure volume, private practice exposure, and ownership of the facility economics separate the top of the distribution from the middle of it, far more than years in practice do.
That leaves an honest question for any employed ophthalmologist looking at that number and wondering where they actually sit inside it. If ownership is what the data says separates the top earners from the average, the more interesting question is what determines the bonus layered on top of it, and whether that bonus rewards judgment, or simply counts procedures.
Educational material only. Figures are illustrative and individual results vary. Statistics are drawn from the Medscape 2026 Ophthalmologist Compensation Report and cited third-party sources. See our Disclosures.
Written by
Verdira Team
Verdira is building a permanent home for ophthalmology practices. We write about succession, physician ownership, and the forces reshaping eye care in the United States.
Ready to secure your legacy?
We're here to ensure your hard work is valued and your business thrives as part of Verdira.
Disclosures
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
The content of this site is for general informational purposes only and is not intended to constitute an offer to sell or a solicitation to buy any security or other asset, or a promise to undertake or solicit business, and may not be relied upon in connection with any offer or sale of securities or other assets.
© 2026 Verdira Management NY, LLC
